Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma

Hepatology Research

Volumn 40, Issue 3, 2010, Pages 330-336

  Ogasawara, Sachiko ^a   Komuta, Mina ^b   Nakashima, Osamu ^a   Akiba, Jun ^a   Tsuneoka, Makoto ^c   Yano, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Hepatocellular carcinoma (HCC); MIB 1 index; Mimitin; Mina53

Indexed keywords

CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN; MITOCHONDRIAL PROTEIN; MYC INDUCED MITOCHONDRIA PROTEIN; MYC INDUCED NUCLEAR ANTIGEN 53; MYC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; COLON CANCER; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; ONCOGENE MYC; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INDUCTION; TUMOR VOLUME;

EID: 77954378537     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00604.x     Document Type: Article

References (29)

1. Tabor E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994, 42:357-65.
2. Caselmann WH. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J Hepatol 1995, 22:34-7.
3. Rogler CE, Chisari FV. Cellular and molecular mechanisms of hepatocarcinogenesis. Semin Liver Dis 1992, 12:265-78.
4. Marcu KB, Bossone SA, Patel AJ. Myc function and regulation. Annu Rev Biochem 1992, 61:809-60.
5. Morgenbesser SD, DePinho RA. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol 1994, 5:21-36.
6. Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 1996, 68:109-82.
7. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-99.
8. Lutz W, Leon J, Eilers M. Contributions of Myc to tumorigenesis. Biochim Biophys Acta 2002, 1602:61-71.
9. Tsuneoka M, Ras MekadaE. /MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras. Oncogene 2000, 19:115-23.
10. Tsuneoka M, Koda Y, Soejima M, Teye K, Kimura H. A novel myc target gene, Mina53, that is involved in cell proliferation. J Biol Chem 2002, 277:35450-9.
11. Tsuneoka M, Teye K, Arima N. A novel Myc-target gene, mimitin, that is involved in cell proliferation of esophageal squamous cell carcinoma. J Biol Chem 2005, 280:19977-85.
12. Tsuneoka M, Fujita H, Arima N. Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. Clin Cancer Res 2004, 10:7347-56.
13. Teye K, Tsuneoka M, Arima N. Increased expression of a Myc target gene Mina53 in human colon cancer. Am J Pathol 2004, 164:205-16.
14. Yaswen P, Goyette M, Shank PR, Fausto N. Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol 1985, 5:780-6.
15. Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N. Sequential protooncogene expression during rat liver regeneration. Cancer Res 1986, 46:3111-17.
16. Zhang XK, Huang DP, Qiu DK, Chiu JF. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 1990, 5:909-14.
17. Arbuthnot P, Kew M, Fitschen W. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res 1991, 11:921-4.
18. Kawate S, Fukusato T, Ohwada S, Watanuki A, Morishita Y. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression. Oncology 1999, 57:157-63.
19. Wang Y, Wu MC, Sham JS, Zhang W, Wu WQ, Guan XY. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 2002, 95:2346-52.
20. Ishizaki H, Yano H, Tsuneoka M. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int 2007, 57:672-80.
21. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-15.
22. Lopez F, Belloc F, Lacombe F. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 1991, 12:42-9.
23. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992, 25:31-40.
24. Fukahori S, Yano H, Tsuneoka M. Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J Pediatr Surg 2007, 42:1831-40.
25. Schmitt-Graff A, Ertelt V, Allgaier HP. Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology 2003, 38:470-80.
26. Morinaga S, Ishiwa N, Noguchi Y. Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma. J Surg Oncol 2005, 92:331-6.
27. Inagawa S, Itabashi M, Adachi S. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 2002, 8:450-6.
28. Shirahashi H, Sakaida I, Terai S, Hironaka K, Kusano N, Okita K. Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma. Liver 2002, 22:413-18.
29. King KL, Hwang JJ, Chau GY. Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 1998, 13:273-9.